¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑÇǺΰúÇÐȸ ¼­¿ïÁöºÎȸ Ä¡·á½ÉÆ÷Áö¿ò : 2022-07-16

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇÑÇǺΰúÇÐȸ ¼­¿ïÁöºÎȸ Ä¡·á½ÉÆ÷Áö¿ò : 2022-07-16
±³À°ÀÏÀÚ : 2022-07-16
±³À°Àå¼Ò : »ïÁ¤È£ÅÚ ¶óº¥´õ·ë  
±³À°ÁÖÁ¦ : ´ëÇÑÇǺΰúÇÐȸ ¼­¿ïÁöºÎȸ Ä¡·á½ÉÆ÷Áö¿ò 
ÁÖÃÖ±â°ü : ´ëÇÑÇǺΰúÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ¼­¿ïÁöºÎȸ  
´ã´çÀÚ : Á¤ÇýÁ¤ ±³¼ö
¿¬¶ôó : 02-2260-7315  
À̸ÞÀÏ : humeong01@nmc.or.kr      
±³À°Á¾·ù : ÇǺΰú      
Âü¼®¿¹»óÀοø : 60¸í
Èñ¸ÁÆòÁ¡ : 3Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 3 ½Ã°£ 30ºÐ  
¼¼ºÎ¼ö°­·á : 500,000¿ø      
ºñ°í ´ëÇÑÇǺΰúÇÐȸ ¼­¿ïÁöºÎȸ ȸ¿ø ÀÌ¿Ü´Â 50¸¸¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 07-16 ¶óº¥´õ·ë 14:05~14:25 Dupilumab vs JAK Inhibitor for atopic dermatitis  ¾ÈÁö¿µ(±¹¸³Áß¾ÓÀÇ·á¿ø) 
±³À°½Ã°£ 07-16 ¶óº¥´õ·ë 14:25~14:45 Safer use of JAK inhibitor  ±è¿ë±æ(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 07-16 ¶óº¥´õ·ë 14:45~15:05 Practical treatment approaches of chronic urticaria in Korea  À̵¿ÈÆ(¼­¿ïÀÇ´ë) 
Åä·Ð 07-16 ¶óº¥´õ·ë 15:05~15:15 Q&A  () 
±³À°½Ã°£ 07-16 ¶óº¥´õ·ë 15:15~15:35 Treatment of nail dystrophy and ingrowing nail  ¿Àº´È£(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 07-16 ¶óº¥´õ·ë 15:35~15:55 Finasteride vs dutasteride for androgenetic alopecia  ÃÖÁö¿õ(¾ÆÁÖÀÇ´ë) 
±³À°½Ã°£ 07-16 ¶óº¥´õ·ë 15:55~16:15 Supportive and adjunctive treatment for hair loss  ÃÖÀ±Áø(¿¬¼¼º½ºûÇǺΰú) 
Åä·Ð 07-16 ¶óº¥´õ·ë 16:15~16:25 Q&A  () 
È޽Ġ07-16 ¶óº¥´õ·ë 16:25~16:50   () 
±³À°½Ã°£ 07-16 ¶óº¥´õ·ë 16:50~17:10 Increasing the usefulness of patch test in allergic contact dermatitis  °íÁÖ¿¬(ÇѾçÀÇ´ë) 
±³À°½Ã°£ 07-16 ¶óº¥´õ·ë 17:10~17:30 My experience of hypopigmenting agents including tranexamic acid in clinical practice  À¯È­Á¤(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 07-16 ¶óº¥´õ·ë 17:30~17:50 RF vs HIFU: basic steps for skin rejuvenation  Á¤¿î°æ(À¯¾ØÁ¤ÇǺΰú) 
Åä·Ð 07-16 ¶óº¥´õ·ë 17:50~18:00 Q&A  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑÇǺΰúÇÐȸ ¼­¿ïÁöºÎȸ Ä¡·á½ÉÆ÷Áö¿ò : 2022-07-16""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2022³âµµ ºÎ»ê±¤¿ª½ÃÀÇ»çȸ Á¦4±â ÀÇ·áÁ¤Ã¥ÃÖ°íÀ§°úÁ¤ : 2022-07-17
´ÙÀ½±Û ¿©¼º½ÉÀåÁúȯ¿¬±¸È¸ ⸳ 10Áֳ⠱â³ä ½ÉÆ÷Áö¾ö : 2022-07-16
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20515 ¼¼Á¾ Ç÷°üÁßÀç½Ã¼ú¿¬±¸È¸ 2024 K-VIS(Korea Vascular Intervention Society) Annual Symposium : 2024-05-17 0 12 2024-04-29
20514 ¼­¿ï ´ëÇÑ·ù¸¶Æ¼½ºÇÐȸ 44th Korean College of Rheumatolgy Annual Scientific Meeting and the 18th International Symposium (KCR2024)-µÑ°³¯ : 2024-05-17 0 7 2024-04-29
20513 ºÎ»ê Á¦54Â÷ ´ëÇѼҾƳ»ºÐºñÇÐȸ Ãá°èÇмú´ëȸ : 2024-05-17 0 22 2024-04-29
20512 ºÎ»ê ´ëÇÑ»êºÎÀΰúÇÐȸ Á¦70Â÷ »êºÎÀΰú ¿¬¼ö°­Á ¹× ¹ßÀü¸ðÀÓ : 2024-05-17 0 15 2024-04-29
20511 ¼­¿ï ´ëÇÑ·ù¸¶Æ¼½ºÇÐȸ 44th Korean College of Rheumatolgy Annual Scientific Meeting and the 18th International Symposium (KCR2024)-ù°³¯ : 2024-05-16 0 16 2024-04-29
20510 ºÎ»ê ´ëÇѺñ´¢ÀÇÇÐȸ 310ȸ Çмú´ëȸ(Àü¸³¼± ¾Ï) : 2024-05-16 0 18 2024-04-29
20509 ¼­¿ï Á¦ 21 ȸ ´ëÇѳú¿°/³ú¿°ÁõÇÐȸ Ãá°èÇмú´ëȸ : 2024-05-15 0 28 2024-04-29
20508 ¼­¿ï (2ÀÏÂ÷) ´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ 2024³â Ãá°è½ÉÆ÷Áö¾ö : 2024-05-14 0 8 2024-04-29
20507 ºÎ»ê ´ëÇÑÁ¤Çü¿Ü°ú ºÎ»ê․¿ï»ê․°æ³²Áöȸ Á¦361Â÷ ¿ù·ÊÇмúȸ : 2024-05-14 0 6 2024-04-29
20506 ¼­¿ï ´ëÇÑÀ̺ñÀÎÈÄ°úÀÇ»çȸ 2024 Áöȸ½ÉÆ÷Áö¾ö-¼­¿ï(°­³²) : 2024-05-14 0 6 2024-04-29
20505 °æ±â ÇѸ²´ëÇб³¼º½Éº´¿ø Æó ¿¬¼ö°­Á : 2024-05-14 0 8 2024-04-29
20504 ¼­¿ï (1ÀÏÂ÷) ´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ 2024³â Ãá°è½ÉÆ÷Áö¾ö : 2024-05-13 0 17 2024-04-29
20503 ´ëÀü Çѱ¹¿©ÀÚÀÇ»çȸ ´ëÀüÁöȸ 5¿ù Çмú½ÉÆ÷Áö¾ö(¾î±ú ÅëÁõÀÇ ¿øÀΰú Ä¡·á) : 2024-05-13 0 15 2024-04-29
20502 °æ±â (¿Â¶óÀÎ) Á¦1Â÷ ±ºÆ÷½ÃÀÇ»çȸ Çмú´ëȸ : 2024-05-12 0 23 2024-04-29
20501 ¼­¿ï Á¦12ȸ ´ëÇÑÀÓ»ó¼øȯ±âÇÐȸ Ãá°èÇмú´ëȸ : 2024-05-12 0 21 2024-04-29
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷